Clinical Trial

Circulating Tumor DNA After Neoadjuvant Chemotherapy

Name: Circulating Tumor DNA After Neoadjuvant Chemotherapy — clinical trial record (NCT03357120)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ALIENOR

Recruiting

View on ClinicalTrials.gov →

Summary

Trial assessing the prognostic value of ctDNA mutations from samples taken sequentially in patients with invasive breast cancer initially treated with neoadjuvant chemotherapy and whose tumor is not in complete histological response.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2017-11-28.

Trial Details

NCT Number	NCT03357120
Lead Sponsor	Institut Bergonié Collaborators: Fondation Bergonié
Conditions	Breast Cancer
Enrollment	180 participants
Start Date	2017-10-06
Primary Completion	2026-10 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2025-10-02